Merck is axing many jobs but others are hiring! Check it out! (Isn’t it tempting?)
Merck & Co, taking a cue from other drugmakers that have slashed research spending to bolster earnings, on Tuesday said it plans to cut annual operating costs by $2.5 billion by the end of 2015 and eliminate 8,500 jobs. By slimming down, Merck aims to narrow its focus to products with the best chance of winning regulatory approval and achieving substantial sales, while jettisoning research products with less likelihood of success. The planned job cuts, representing more than 10 percent of the company’s global workforce of 81,000 employees, would be in addition to previously announced cuts of 7,500 positions.
Don’t forget, hundreds of biopharma companies are hiring! (We know you can’t resist.)
